PMID- 33183028 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20210514 IS - 2224-5839 (Electronic) IS - 2224-5820 (Linking) VI - 10 IP - 2 DP - 2021 Feb TI - Evaluation of maternal and fetal outcomes in pregnancy complicated with pulmonary arterial hypertension. PG - 1404-1410 LID - 10.21037/apm-20-551 [doi] AB - BACKGROUND: Pulmonary arterial hypertension (PAH) is an uncommon type of pulmonary hypertension (PH) disease characterized by progressive remodeling of distal pulmonary arteries. It could inevitably lead to pulmonary vascular resistance and even right ventricular failure. Biologists have explored the basic pathobiology of PAH, but its functional mechanism and effect in pregnant people remain unknown. This study was designed to investigate the maternal and fetal outcomes of pregnancy-related PAH. METHODS: Clinical data of 59 pregnant women with PAH who were admitted to Peking Union Medical College Hospital from Jan. 2000 to Dec. 2018 were retrospectively reviewed and analyzed. Multiple parameters, including age, gestational week, the New York Heart Association (NYHA) cardiac functional classification, ultrasonic cardiogram (UCG), blood test, pregnancy complications, pulmonary arterial systolic pressure, maternal and fetal outcomes, were comprehensively investigated and analyzed. RESULTS: According to the pulmonary arterial systolic pressure, all 59 pregnant women were divided into mild PAH (30-49 mmHg, n=18), moderate PAH (50-79 mmHg, n=17) and severe PAH (>79 mmHg, n=24). Five patients died, and the mortality rate was 8.5%. Compared with the mild and moderate groups, the mean gestational week, age of the pregnancy, and NYHA cardiac functional classification grade in the severe PAH group were dramatically different (all P<0.05). The incidence of pregnancy-related complications in the severe PAH group was significantly higher than those in the mild and moderate PAH groups (both P<0.05). CONCLUSIONS: The blood parameters, PAH, and NYHA cardiac functional classification grade were significantly changed before and after surgery. We found that the severity of PAH was a major factor of maternal and fetal outcomes. Strengthening the nursing care for pregnant women with PAH is of great clinical significance. FAU - Zhou, Qian AU - Zhou Q AD - Department of Obstertrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China. FAU - Peng, Ping AU - Peng P AD - Department of Obstertrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China. pengping2164@sina.com. FAU - Liu, Xinyan AU - Liu X AD - Department of Obstertrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China. FAU - Liu, Juntao AU - Liu J AD - Department of Obstertrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China. FAU - Gao, Jinsong AU - Gao J AD - Department of Obstertrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China. FAU - Chen, Weilin AU - Chen W AD - Department of Obstertrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China. LA - eng PT - Journal Article DEP - 20201029 PL - China TA - Ann Palliat Med JT - Annals of palliative medicine JID - 101585484 SB - IM MH - Cesarean Section MH - Familial Primary Pulmonary Hypertension MH - Female MH - Humans MH - Pregnancy MH - Pregnancy Outcome MH - *Pulmonary Arterial Hypertension MH - Retrospective Studies OTO - NOTNLM OT - NYHA functional classification OT - Pulmonary arterial hypertension (PAH) OT - maternal and fetal outcome OT - pregnancy OT - severity EDAT- 2020/11/14 06:00 MHDA- 2021/05/15 06:00 CRDT- 2020/11/13 05:31 PHST- 2020/03/05 00:00 [received] PHST- 2020/08/19 00:00 [accepted] PHST- 2020/11/14 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2020/11/13 05:31 [entrez] AID - apm-20-551 [pii] AID - 10.21037/apm-20-551 [doi] PST - ppublish SO - Ann Palliat Med. 2021 Feb;10(2):1404-1410. doi: 10.21037/apm-20-551. Epub 2020 Oct 29.